MX2009008994A - Composicion farmaceutica para la prevencion o tratamiento de enfermedades asociadas con la reduccion de lagrimas. - Google Patents
Composicion farmaceutica para la prevencion o tratamiento de enfermedades asociadas con la reduccion de lagrimas.Info
- Publication number
- MX2009008994A MX2009008994A MX2009008994A MX2009008994A MX2009008994A MX 2009008994 A MX2009008994 A MX 2009008994A MX 2009008994 A MX2009008994 A MX 2009008994A MX 2009008994 A MX2009008994 A MX 2009008994A MX 2009008994 A MX2009008994 A MX 2009008994A
- Authority
- MX
- Mexico
- Prior art keywords
- carbon atom
- prevention
- pharmaceutical composition
- treatment
- disease associated
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 5
- 125000004432 carbon atom Chemical group C* 0.000 abstract 5
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 3
- 206010013774 Dry eye Diseases 0.000 abstract 3
- 125000003277 amino group Chemical group 0.000 abstract 2
- 208000030533 eye disease Diseases 0.000 abstract 2
- 206010010736 Conjunctival ulcer Diseases 0.000 abstract 1
- 208000009319 Keratoconjunctivitis Sicca Diseases 0.000 abstract 1
- 208000021386 Sjogren Syndrome Diseases 0.000 abstract 1
- 206010042033 Stevens-Johnson syndrome Diseases 0.000 abstract 1
- 231100000168 Stevens-Johnson syndrome Toxicity 0.000 abstract 1
- 206010064996 Ulcerative keratitis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000002723 alicyclic group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 201000007717 corneal ulcer Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000005494 xerophthalmia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proporciona una composición farmacéutica para la prevención o tratamiento de una enfermedad asociada con la reducción en las lágrimas. Se describe una composición farmacéutica para la prevención o tratamiento de una enfermedad asociada con la reducción de las lágrimas (ojos secos, queratoconjuntivitis sicca, enfermedad del epitelio de la córnea, alacrima, xeroftalmia, ojos secos relacionados con la edad, enfermedades de los ojos en el síndrome de Stevens-Johnson, enfermedad de los ojos en el síndrome de Sjögren, una úlcera de la córnea/conjuntival, resequedad durante el uso de lentes de contacto), la cual comprende derivados de amida de ácido feniletanolaminotetralincarboxílico representado por la fórmula general (I), o una sal farmacológicamente aceptable del mismo o similares como ingrediente activo. (I) en donde A representa un grupo alquileno inferior, B representa un grupo amino, un grupo di-alquilamino inferior, o un grupo amino alicíclico de 3 a 7 miembros el cual puede tener un átomo de oxígeno en el anillo, un átomo de carbono marcado con un asterisco "*" representa un átomo de carbono que tiene una configuración R- o S-, o un átomo de carbono que tiene una configuración R/S mezclada; y un átomo de carbono marcado con (S) representa un átomo de carbono que tiene una configuración-S.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007040191 | 2007-02-21 | ||
| PCT/JP2008/052814 WO2008102790A1 (ja) | 2007-02-21 | 2008-02-20 | 涙液の減少に伴う疾患の予防または治療用医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009008994A true MX2009008994A (es) | 2009-09-03 |
Family
ID=39710064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009008994A MX2009008994A (es) | 2007-02-21 | 2008-02-20 | Composicion farmaceutica para la prevencion o tratamiento de enfermedades asociadas con la reduccion de lagrimas. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110092509A1 (es) |
| EP (1) | EP2123268A1 (es) |
| JP (1) | JPWO2008102790A1 (es) |
| AU (1) | AU2008218028A1 (es) |
| BR (1) | BRPI0807715A2 (es) |
| CA (1) | CA2677582A1 (es) |
| MX (1) | MX2009008994A (es) |
| WO (1) | WO2008102790A1 (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG55296A1 (en) | 1996-04-12 | 1998-12-21 | Kissei Pharmaceutical | Phenylethalolaminotetralincarboxamide derivatives |
| WO2001041806A1 (en) | 1999-12-07 | 2001-06-14 | Rohto Pharmaceutical Co., Ltd. | Ophthalmic compositions |
| CA2619445A1 (en) * | 2005-08-29 | 2007-03-08 | Kissei Pharmaceutical Co., Ltd. | Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
-
2008
- 2008-02-20 CA CA002677582A patent/CA2677582A1/en not_active Abandoned
- 2008-02-20 JP JP2009500203A patent/JPWO2008102790A1/ja active Pending
- 2008-02-20 EP EP08711620A patent/EP2123268A1/en not_active Withdrawn
- 2008-02-20 AU AU2008218028A patent/AU2008218028A1/en not_active Abandoned
- 2008-02-20 BR BRPI0807715-0A patent/BRPI0807715A2/pt not_active IP Right Cessation
- 2008-02-20 MX MX2009008994A patent/MX2009008994A/es not_active Application Discontinuation
- 2008-02-20 WO PCT/JP2008/052814 patent/WO2008102790A1/ja not_active Ceased
-
2009
- 2009-08-07 US US12/526,298 patent/US20110092509A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2123268A1 (en) | 2009-11-25 |
| US20110092509A1 (en) | 2011-04-21 |
| JPWO2008102790A1 (ja) | 2010-05-27 |
| WO2008102790A1 (ja) | 2008-08-28 |
| CA2677582A1 (en) | 2008-08-28 |
| BRPI0807715A2 (pt) | 2014-06-03 |
| AU2008218028A1 (en) | 2008-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sturdivant et al. | Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma | |
| WO2010004435A3 (en) | Ph specific solutions of sodium mycophenolic acid for the treatment of eye disorders | |
| US20120238623A1 (en) | Inflammation and Autoimmune Disorder Treatment using RARa Selective Agonists | |
| EA027828B1 (ru) | Противовирусные соединения | |
| JP2001511806A (ja) | 神経栄養性スルホンアミド化合物の使用方法 | |
| US20110275693A1 (en) | Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives | |
| EA201270505A1 (ru) | Производные иминотиадиазиндиоксида в качестве ингибиторов bace, композиции на их основе, и их применение | |
| WO2011159550A3 (en) | Lysophosphatidic acid receptor antagonist and uses thereof | |
| US10822301B2 (en) | 3-carbon substituted 4-aminocyclopent-1-ene-1-carboxylic acid compounds as inhibitors of gamma-aminobutyric acid (GABA) aminotransferase | |
| RU2014122858A (ru) | Лечение когнитивных расстройств (r)-7-хлор-n-(хинуклидин-3-ил)бензо[в]тиофен-2-карбосамидом и его фармацевтически приемлемыми солями | |
| WO2007012064A2 (en) | Prevention and treatment of hearing disorders | |
| TN2009000253A1 (en) | Solid dispersion of a neurokinin antagonist | |
| CN102066402B (zh) | 肽衍生物以及含有肽衍生物的用于促进泪液分泌的组合物 | |
| WO2024100452A3 (en) | Heterocyclic compounds as sting agonists | |
| MX2012001160A (es) | Agonistas del receptor de esfingosina-1-fosfato. | |
| MX2009007040A (es) | Derivados de mononitrato de isosorbida para el tratamiento de hipertension ocular. | |
| JP2003508512A (ja) | 非ペプチド性サイクロフィリン結合化合物とその用途 | |
| US20080261984A1 (en) | Use of S,S-Reboxetine in the Treatment of Pain | |
| HRP20120231T1 (hr) | Upotreba derivata indola kao aktivatora nurr-1 u liječenju parkinsonove bolesti | |
| MX2009008994A (es) | Composicion farmaceutica para la prevencion o tratamiento de enfermedades asociadas con la reduccion de lagrimas. | |
| US20110263642A1 (en) | Methods for treatment of multiple sclerosis | |
| US10434097B1 (en) | Methods and compositions for treating hearing disorders | |
| CA2805371C (en) | Therapeutic agent or prophylactic agent for neuropathic pain | |
| EP1935417A4 (en) | COMPOSITION FOR USE IN PREVENTING A HYPOGLYCEMIC STATE | |
| RU2013126056A (ru) | Композиция для лечения нарушений иннерваций (варианты) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |